<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2021.740273</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Briston</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stephen</surname>
<given-names>Jenna M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thomas</surname>
<given-names>Luke W.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/413055"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Esposito</surname>
<given-names>Cinzia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1028512"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chung</surname>
<given-names>Yuen-Li</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/362567"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Syafruddin</surname>
<given-names>Saiful E.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turmaine</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/428474"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maddalena</surname>
<given-names>Lucas A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greef</surname>
<given-names>Basma</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Szabadkai</surname>
<given-names>Gyorgy</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/31063"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maxwell</surname>
<given-names>Patrick H.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1457681"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vanharanta</surname>
<given-names>Sakari</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ashcroft</surname>
<given-names>Margaret</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/285859"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Division of Medicine, Centre for Cell Signalling and Molecular Genetics, University College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medicine, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Cancer Research UK Cancer Imaging Centre, Institute of Cancer Research London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Medical Research Council Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Division of Biosciences, Department of Cell and Developmental Biology, University College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>The Francis Crick Institute</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Biomedical Sciences, University of Padua</institution>, <addr-line>Padua</addr-line>, <country>Italy</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Cambridge Institute for Medical Research, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and reviewed by: Keith R. Laderoute, Consultant, Redwood City, CA, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Margaret Ashcroft, <email xlink:href="mailto:m.ashcroft@medschl.cam.ac.uk">m.ashcroft@medschl.cam.ac.uk</email>
</p>
</fn>
<fn fn-type="present-address" id="fn003">
<p>&#x2020;Present Address: Thomas Briston, Hatfield Research Laboratories, Neurology Innovation Centre, Eisai Ltd., Hatfield, United Kingdom</p>
</fn>
<fn fn-type="equal" id="fn004">
<p>&#x2021;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>11</volume>
<elocation-id>740273</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>08</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Briston, Stephen, Thomas, Esposito, Chung, Syafruddin, Turmaine, Maddalena, Greef, Szabadkai, Maxwell, Vanharanta and Ashcroft</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Briston, Stephen, Thomas, Esposito, Chung, Syafruddin, Turmaine, Maddalena, Greef, Szabadkai, Maxwell, Vanharanta and Ashcroft</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fonc.2018.00388" ext-link-type="doi">A Corrigendum on <article-title>VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function</article-title> By Briston T, Stephen JM, Thomas LW, Esposito C, Chung Y-L, Syafruddin SE, Turmaine M, Maddalena LA, Greef B, Szabadkai G, Maxwell PH, Vanharanta S and Ashcroft M (2018). Front. Oncol. 8:388. doi:&#xa0;<object-id>10.3389/fonc.2018.00388</object-id>
</related-article>
<kwd-group>
<kwd>Hippel-Lindau protein (pVHL)</kwd>
<kwd>hypoxia inducible factor</kwd>
<kwd>mitochondria</kwd>
<kwd>bioenergetics</kwd>
<kwd>metabolism</kwd>
<kwd>CHCHD4</kwd>
<kwd>respiratory chain</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="371"/>
</counts>
</article-meta>
</front>
<body>
<p>In the original article, there was a mistake in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref> as published. The figure text was mislabeled, and a lane-line was missing. The corrected <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> appears below.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>pVHL mutants differentially regulate mitochondrial protein expression, mtDNA copy number and ATP levels. <bold>(A)</bold> Western blots show HIF-1&#x3b1;, HIF-2&#x3b1;, GLUT-1, and BNIP3 protein levels in RCC10 cells expressing empty vector (pCMV), wild type pVHL (VHL), or pVHL mutants (R200W or N78S). &#x3b1;-tubulin and &#x3b2;-actin were used as load controls. <bold>(B)</bold> Relative expression of PHD3 mRNA in RCC10 cells described in <bold>(A)</bold>, measured using RT-qPCR. Data were analyzed using the comparative Ct method. Data are presented as mean &#xb1; S.E.M. n = 3 (n.s. p &gt; 0.05, *p &lt; 0.05, and ***p &lt; 0.001). <bold>(C)</bold> Western blots show expression of mitochondrial proteins CHCHD4 and VDAC1, and respiratory chain subunits NDUFB10 (CI), SDHA (CII), UQCRC2 (CIII), COX IV (CIV) in RCC10 cells described in <bold>(A)</bold>. pVHL expression was assessed as a control for re-expression, and &#x3b2;-actin and &#x3b1;-tubulin were used as load controls. <bold>(D)</bold> Graph shows total cellular ATP content in RCC10 cells expressing wild type pVHL (VHL) or pVHL mutants (R200W or N78S), normalized to cell number (n = 4). <bold>(E)</bold> Graph shows mtDNA copy number in RCC10 cells expressing pVHL variants, calculated using the ratio of expression of mitochondrial ND1 gene to the single copy nuclear gene, <italic>&#x3b2;</italic>2M to by RT-qPCR. Data in <bold>(D, E)</bold> are presented as mean &#xb1; S.D. n = 6 (n.s. p &gt; 0.05, *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-11-740273-g004.tif"/>
</fig>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
</article>